These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Novel Phenylene Lipids That Are Positive Allosteric Modulators of Glycine Receptors and Inhibitors of Glycine Transporter 2. Gallagher CI; Frangos ZJ; Sheipouri D; Shimmon S; Duman MN; Jayakumar S; Cioffi CL; Rawling T; Vandenberg RJ ACS Chem Neurosci; 2023 Aug; 14(15):2634-2647. PubMed ID: 37466545 [TBL] [Abstract][Full Text] [Related]
11. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain. Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830 [TBL] [Abstract][Full Text] [Related]
12. Neurobiology of glycine transporters: From molecules to behavior. Marques BL; Oliveira-Lima OC; Carvalho GA; de Almeida Chiarelli R; Ribeiro RI; Parreira RC; da Madeira Freitas EM; Resende RR; Klempin F; Ulrich H; Gomez RS; Pinto MCX Neurosci Biobehav Rev; 2020 Nov; 118():97-110. PubMed ID: 32712279 [TBL] [Abstract][Full Text] [Related]
13. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867 [TBL] [Abstract][Full Text] [Related]
14. Transport activities and expression patterns of glycine transporters 1 and 2 in the developing murine brain stem and spinal cord. Lall D; Armbruster A; Ruffert K; Betz H; Eulenburg V Biochem Biophys Res Commun; 2012 Jul; 423(4):661-6. PubMed ID: 22695116 [TBL] [Abstract][Full Text] [Related]
15. Lidocaine metabolites inhibit glycine transporter 1: a novel mechanism for the analgesic action of systemic lidocaine? Werdehausen R; Kremer D; Brandenburger T; Schlösser L; Jadasz J; Küry P; Bauer I; Aragón C; Eulenburg V; Hermanns H Anesthesiology; 2012 Jan; 116(1):147-58. PubMed ID: 22133759 [TBL] [Abstract][Full Text] [Related]
16. Glycine transporter inhibitors: A new avenue for managing neuropathic pain. Al-Khrasani M; Mohammadzadeh A; Balogh M; Király K; Barsi S; Hajnal B; Köles L; Zádori ZS; Harsing LG Brain Res Bull; 2019 Oct; 152():143-158. PubMed ID: 31302238 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of inhibitory glycinergic neurotransmission by Zn2+: a synergistic interplay between presynaptic P2X2 and postsynaptic glycine receptors. Laube B Eur J Neurosci; 2002 Sep; 16(6):1025-36. PubMed ID: 12383231 [TBL] [Abstract][Full Text] [Related]
18. Oleoyl-L-carnitine inhibits glycine transport by GlyT2. Carland JE; Mansfield RE; Ryan RM; Vandenberg RJ Br J Pharmacol; 2013 Feb; 168(4):891-902. PubMed ID: 22978602 [TBL] [Abstract][Full Text] [Related]
19. The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain. Werdehausen R; Mittnacht S; Bee LA; Minett MS; Armbruster A; Bauer I; Wood JN; Hermanns H; Eulenburg V Pain; 2015 Sep; 156(9):1647-1659. PubMed ID: 25932687 [TBL] [Abstract][Full Text] [Related]
20. Positive allosteric modulators differentially affect full versus partial agonist activation of the glycine receptor. Kirson D; Todorovic J; Mihic SJ J Pharmacol Exp Ther; 2012 Jul; 342(1):61-70. PubMed ID: 22473615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]